This data positions "survodutide as a potential leading treatment for a population with great unmet medical needs, and will bring hope to people living with MASH and with fibrosis,” commented Dr ...

Madrigal Pharma has become the first drugmaker to claim FDA approval for a drug to treat metabolic dysfunction-associated steatohepatitis (MASH), an elusive target that has seen many other ...

‘M*A*S*H’ remains one of the most beloved television shows of all time. Cast members are sitting down for new interviews as they reflect on the iconic show decades later. See the cast then and ...